CVR: 56759514
Secondary names: LEO A/S, LEO INDUSTRIES A/S, LEO GROUP A/S
Previous names: LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Philip Harald Eickhoff and Christophe Dominique Luc Charles Bourdon. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 2,040 employees. In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity amounted to DKK 5,262,000,000.
LEO PHARMA A/S has shown a remarkable turnaround in financial health, achieving a significant revenue increase from 9.96 billion DKK in 2021 to 13.50 billion DKK in 2025, alongside a return to profitability with a profit of 2.49 billion DKK in 2025. Despite facing substantial losses in previous years, the company's equity has also improved, rising to 5.26 billion DKK in 2025 from a low of 1.95 billion DKK in 2022. Key strengths include its robust revenue growth and recovery in profit margins, although concerns remain regarding its past losses and overall debt management. With over 1,000 employees, LEO PHARMA holds a significant position in the pharmaceutical manufacturing industry, indicating resilience and potential for future growth.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive industrivirksomhed og handel.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 13.5 mia. | 2.5 mia. | 20.4 mia. | 5.3 mia. | 4104 | |
| 2024 | 12.5 mia. | -1.8 mia. | 20.2 mia. | 2.7 mia. | 4184 | |
| 2023 | 11.4 mia. | -3.6 mia. | 21 mia. | 4.5 mia. | 4490 | |
| 2022 | 10.6 mia. | -4.1 mia. | 22.9 mia. | 1.9 mia. | 5252 | |
| 2021 | 10 mia. | -4.9 mia. | 23.7 mia. | 5.5 mia. | - | |
| 2020 | 10.1 mia. | -951 mio. | 23.9 mia. | 6.9 mia. | - | |
| 2019 | 10.8 mia. | -1.3 mia. | 24.8 mia. | 8.1 mia. | - | |
| 2018 | 10.4 mia. | 1.3 mia. | 16.3 mia. | 9.5 mia. | - | |
| 2017 | 10.5 mia. | 1.4 mia. | 14.6 mia. | 8.3 mia. | - | |
| 2016 | 7.4 mia. | 743 mio. | 37.8 mia. | 25.2 mia. | 5170 | |
| 2015 | 6.9 mia. | 645 mio. | 35.6 mia. | 25.3 mia. | 4813 | |
| 2014 | 6.6 mia. | 1.5 mia. | 34.6 mia. | 24.5 mia. | 4712 | |
| 2013 | 5.8 mia. | 1.2 mia. | 33 mia. | 23.1 mia. | 4733 |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
1 public tender won
Sources: TED (the EU tender database) and udbud.dk
3 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Screen owners and management against the Danish FSA's official PEP lists
LEO PHARMA A/S has published its annual report for 2025. Revenue came to DKK 13,499,000,000, and the net result was DKK 2,489,000,000.
As of February 25, 2026, Thomas Christian Facius has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Peter Helt Jacobsen Haahr has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Henrik Bo Andersson has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Kasper Fangel has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Allan Carsten Dahl has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Karen Louise Lauesen has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Christina Dahl has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Thomas Christian Vaarby has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Rifat Ramicevic has left the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Jannie Kogsbøll has left the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Klaus Legau has left the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Poul Bo Kilund has left the board of directors of LEO PHARMA A/S.
As of February 25, 2026, Lars Green has left the board of directors of LEO PHARMA A/S.
As of February 24, 2026, Thomas Christian Facius has left the board of directors of LEO PHARMA A/S.
As of February 24, 2026, Peter Helt Jacobsen Haahr has left the board of directors of LEO PHARMA A/S.
As of February 24, 2026, Henrik Bo Andersson has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 368,505,024 DKK.
As of June 27, 2025, Rifat Ramicevic has joined the board of directors of LEO PHARMA A/S.
As of June 27, 2025, Kreesten Meldgaard Madsen has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2024. Revenue came to DKK 12,453,000,000, and the net result was DKK -1,776,000,000.
As of March 13, 2025, Poul Bo Kilund has joined the board of directors of LEO PHARMA A/S.
As of March 13, 2025, Sara Melissa Plov Hoff has left the board of directors of LEO PHARMA A/S.
As of March 5, 2025, Aino Anna Liisa Hurme has joined the board of directors of LEO PHARMA A/S.
As of March 5, 2025, Mark Philip Levick has joined the board of directors of LEO PHARMA A/S.
As of July 31, 2024, Johannes Gerardus Joseph van de Winkel has left the board of directors of LEO PHARMA A/S.
As of April 24, 2024, Raj Rashmikant Shah has joined the board of directors of LEO PHARMA A/S.
As of April 24, 2024, Jonas Wilhelm Agnblad has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2023. Revenue came to DKK 11,392,000,000, and the net result was DKK -3,607,000,000.
As of March 1, 2024, Thomas Christian Facius has joined the board of directors of LEO PHARMA A/S.
As of March 1, 2024, Henrik Bo Andersson has joined the board of directors of LEO PHARMA A/S.
As of March 1, 2024, Karin Attermann has left the board of directors of LEO PHARMA A/S.
As of February 29, 2024, Henrik Bo Andersson has left the board of directors of LEO PHARMA A/S.
As of February 29, 2024, Jesper Mailind has left the board of directors of LEO PHARMA A/S.
As of September 20, 2023, is registered as an owner of LEO PHARMA A/S with an ownership share of 15%.
As of April 1, 2023, Sara Melissa Plov Hoff has joined the board of directors of LEO PHARMA A/S.
As of April 1, 2023, Thorsten Erik Ramsing has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2022. Revenue came to DKK 10,641,000,000, and the net result was DKK -4,110,000,000.
As of March 8, 2023, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of March 8, 2023, Paul Olivier Marie Navarre has joined the board of directors of LEO PHARMA A/S.
As of March 7, 2023, Jesper Mailind has left the board of directors of LEO PHARMA A/S.
As of March 7, 2023, Paul Olivier Marie Navarre has left the board of directors of LEO PHARMA A/S.
As of September 15, 2022, Philip Harald Eickhoff is registered as director of LEO PHARMA A/S.
As of September 15, 2022, Anders Kronborg has stepped down as director of LEO PHARMA A/S.
As of August 29, 2022, Paul Olivier Marie Navarre has joined the board of directors of LEO PHARMA A/S.
As of July 1, 2022, Klaus Legau has joined the board of directors of LEO PHARMA A/S.
As of July 1, 2022, Louisa Channouf Jacobsen has left the board of directors of LEO PHARMA A/S.
As of June 24, 2022, Lena Elisabeth Svanberg has joined the board of directors of LEO PHARMA A/S.
As of April 1, 2022, Anders Kronborg is registered as director of LEO PHARMA A/S.
As of April 1, 2022, Christophe Dominique Luc Charles Bourdon is registered as adm. dir. of LEO PHARMA A/S.
As of March 31, 2022, Anders Kronborg has stepped down as adm. dir. of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2021. Revenue came to DKK 9,957,000,000, and the net result was DKK -4,868,000,000.
As of March 16, 2022, Kreesten Meldgaard Madsen has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Signe Maria Christensen has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Thorsten Erik Ramsing has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Jannie Kogsbøll has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Henrik Bo Andersson has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Karin Attermann has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Louisa Channouf Jacobsen has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Franck Maréno has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Rifat Ramicevic has left the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Thomas Christian Facius has left the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Sammy Islam Al-Moalem has left the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Jane Maria Birgitta Stymne Göransson has left the board of directors of LEO PHARMA A/S.
As of March 16, 2022, Anders Ekblom has left the board of directors of LEO PHARMA A/S.
As of March 15, 2022, Signe Maria Christensen has left the board of directors of LEO PHARMA A/S.
As of March 15, 2022, Jannie Kogsbøll has left the board of directors of LEO PHARMA A/S.
As of March 15, 2022, Henrik Bo Andersson has left the board of directors of LEO PHARMA A/S.
As of March 15, 2022, Karin Attermann has left the board of directors of LEO PHARMA A/S.
As of March 15, 2022, Jesper Mailind has left the board of directors of LEO PHARMA A/S.
As of March 15, 2022, Franck Maréno has left the board of directors of LEO PHARMA A/S.
As of November 30, 2021, Anders Kronborg is registered as adm. dir. of LEO PHARMA A/S.
As of November 30, 2021, Catherine Thérése Jeanne Mazzacco has stepped down as adm. dir. of LEO PHARMA A/S.
As of November 29, 2021, Anders Kronborg has stepped down as director of LEO PHARMA A/S.
As of September 13, 2021, Peter Helt Jacobsen Haahr has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2021, Jesper Brandgaard has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2021, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2021, Anders Ekblom has joined the board of directors of LEO PHARMA A/S.
As of July 31, 2021, Jesper Mailind has left the board of directors of LEO PHARMA A/S.
As of July 31, 2021, Anders Ekblom has left the board of directors of LEO PHARMA A/S.
As of July 21, 2021, Jonas Wilhelm Agnblad has joined the board of directors of LEO PHARMA A/S.
As of July 21, 2021, LEO Holding A/S is registered as an owner of LEO PHARMA A/S with an ownership share of 66%.
As of May 6, 2021, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of May 6, 2021, Anders Ekblom has joined the board of directors of LEO PHARMA A/S.
As of May 6, 2021, Olivier Bohuon has left the board of directors of LEO PHARMA A/S.
As of May 5, 2021, Jesper Mailind has left the board of directors of LEO PHARMA A/S.
As of May 5, 2021, Anders Ekblom has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2020. Revenue came to DKK 10,133,000,000, and the net result was DKK -951,000,000.
As of March 16, 2021, Lars Green has joined the board of directors of LEO PHARMA A/S.
As of March 16, 2021, Cristina Patricia Lage has left the board of directors of LEO PHARMA A/S.
As of March 16, 2021, Jesper Høiland has left the board of directors of LEO PHARMA A/S.
As of February 11, 2021, Thomas Christian Facius has joined the board of directors of LEO PHARMA A/S.
As of February 11, 2021, Fie Falck Bruus Madsen has left the board of directors of LEO PHARMA A/S.
As of July 2, 2020, Rifat Ramicevic has joined the board of directors of LEO PHARMA A/S.
As of July 2, 2020, Laurids Bonne Bjørnshauge has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2019. Revenue came to DKK 10,805,000,000, and the net result was DKK -1,287,000,000.
As of February 25, 2020, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.
As of November 13, 2019, Jane Maria Birgitta Stymne Göransson has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2019, Catherine Thérése Jeanne Mazzacco is registered as adm. dir. of LEO PHARMA A/S.
As of July 31, 2019, Gitte Pugholm Aabo has stepped down as adm. dir. of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2018. Revenue came to DKK 10,410,000,000, and the net result was DKK 1,258,000,000.
As of February 26, 2019, Anders Ekblom has joined the board of directors of LEO PHARMA A/S.
As of February 26, 2019, Olivier Bohuon has joined the board of directors of LEO PHARMA A/S.
As of February 26, 2019, Jukka Pekka Pertola has left the board of directors of LEO PHARMA A/S.
As of February 26, 2019, John Robert Weeks has left the board of directors of LEO PHARMA A/S.
As of February 25, 2019, Laurids Bonne Bjørnshauge has joined the board of directors of LEO PHARMA A/S.
As of February 25, 2019, Irene Anett Jonassen has left the board of directors of LEO PHARMA A/S.
As of February 25, 2019, Anders Ekblom has left the board of directors of LEO PHARMA A/S.
As of February 25, 2019, Olivier Bohuon has left the board of directors of LEO PHARMA A/S.
As of August 27, 2018, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of August 27, 2018, Olivier Bohuon has joined the board of directors of LEO PHARMA A/S.
As of August 26, 2018, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2017. Revenue came to DKK 10,481,000,000, and the net result was DKK 1,381,000,000.
As of February 27, 2018, Signe Maria Christensen has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Henrik Bo Andersson has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Franck Maréno has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Fie Falck Bruus Madsen has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Sammy Islam Al-Moalem has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Irene Anett Jonassen has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Anders Ekblom has joined the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Lars Kjøller has left the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Ingelise Saunders has left the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Jan Rasmussen has left the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Lotte Hjortshøj has left the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Peder Holk Nielsen has left the board of directors of LEO PHARMA A/S.
As of February 27, 2018, Allan Carsten Dahl has left the board of directors of LEO PHARMA A/S.
As of May 23, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LEO PHARMA A/S.
As of May 23, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2016. Revenue came to DKK 7,360,000,000, and the net result was DKK 743,000,000.
As of March 30, 2017, Cristina Patricia Lage has joined the board of directors of LEO PHARMA A/S.
As of March 30, 2017, Johannes Gerardus Joseph van de Winkel has joined the board of directors of LEO PHARMA A/S.
As of March 30, 2017, Jens Bo Olesen has left the board of directors of LEO PHARMA A/S.
As of December 9, 2016, Jan Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of December 9, 2016, Morten Drewes Pedersen has left the board of directors of LEO PHARMA A/S.
As of June 24, 2016, Jesper Høiland has joined the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2015. Revenue came to DKK 6,876,000,000, and the net result was DKK 645,000,000.
As of January 1, 2016, Jukka Pekka Pertola has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2016, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2016, Poul Rødbroe Rasmussen has left the board of directors of LEO PHARMA A/S.
As of December 31, 2015, Jukka Pekka Pertola has left the board of directors of LEO PHARMA A/S.
As of December 31, 2015, Patrik Olof Dahlén has left the board of directors of LEO PHARMA A/S.
As of December 31, 2015, Lars Olsen has stepped down as director of LEO PHARMA A/S.
As of October 1, 2015, Anders Kronborg is registered as director of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2014. Revenue came to DKK 6,571,000,000, and the net result was DKK 1,544,000,000.
As of April 21, 2015, Jukka Pekka Pertola has joined the board of directors of LEO PHARMA A/S.
As of April 21, 2015, Patrik Olof Dahlén has joined the board of directors of LEO PHARMA A/S.
As of April 20, 2015, Jukka Pekka Pertola has left the board of directors of LEO PHARMA A/S.
As of October 22, 2014, Lars Kjøller has joined the board of directors of LEO PHARMA A/S.
As of October 22, 2014, Marianne Viskum Olesen has left the board of directors of LEO PHARMA A/S.
As of June 30, 2014, Anders Bendsen Spohr has stepped down as director of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2013. Revenue came to DKK 5,782,000,000, and the net result was DKK 1,175,000,000.
As of March 27, 2014, Ingelise Saunders has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Morten Drewes Pedersen has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Allan Carsten Dahl has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Marianne Viskum Olesen has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, John Robert Weeks has joined the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Per Håkon Schmidt has left the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Gorm Milan Thamsborg has left the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Jens Vallentin Holm has left the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Jan Rasmussen has left the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Mette Bonde Eliasson has left the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Ann Berit Sveigaard has left the board of directors of LEO PHARMA A/S.
As of March 27, 2014, Morten Drewes Pedersen has left the board of directors of LEO PHARMA A/S.
LEO PHARMA A/S has published its annual report for 2012.
As of March 1, 2012, Anders Bendsen Spohr is registered as director of LEO PHARMA A/S.
As of February 29, 2012, John Carsten Mehlbye has stepped down as director of LEO PHARMA A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LEO PHARMA A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of LEO PHARMA A/S.
As of March 28, 2011, Jukka Pekka Pertola has joined the board of directors of LEO PHARMA A/S.
As of March 28, 2011, Peder Holk Nielsen has joined the board of directors of LEO PHARMA A/S.
As of March 28, 2011, John Carsten Mehlbye has left the board of directors of LEO PHARMA A/S.
As of March 28, 2011, Lars Olsen has left the board of directors of LEO PHARMA A/S.
As of March 28, 2011, Gitte Pugholm Aabo has left the board of directors of LEO PHARMA A/S.
As of March 28, 2011, Nina Sølver Henning has left the board of directors of LEO PHARMA A/S.
As of July 1, 2010, Jens Bo Olesen has stepped down as director of LEO PHARMA A/S.
As of March 24, 2010, A/S PSE NR. 4820 has been appointed auditor of LEO PHARMA A/S.
As of March 24, 2010, RVT REVISIONSTJENESTEN A/S has stepped down as auditor of LEO PHARMA A/S.
As of March 24, 2010, Jens Vallentin Holm has joined the board of directors of LEO PHARMA A/S.
As of March 24, 2010, Jan Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of March 24, 2010, Lotte Hjortshøj has joined the board of directors of LEO PHARMA A/S.
As of March 24, 2010, Mette Bonde Eliasson has joined the board of directors of LEO PHARMA A/S.
As of March 24, 2010, Ann Berit Sveigaard has joined the board of directors of LEO PHARMA A/S.
As of March 24, 2010, Morten Drewes Pedersen has joined the board of directors of LEO PHARMA A/S.
As of March 24, 2010, Judith Blankholm has left the board of directors of LEO PHARMA A/S.
As of November 17, 2008, Poul Rødbroe Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of November 17, 2008, Ernst Lunding has left the board of directors of LEO PHARMA A/S.
As of June 30, 2008, Birgitte Pryds has left the board of directors of LEO PHARMA A/S.
As of January 1, 2008, John Carsten Mehlbye has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2008, Lars Olsen has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2008, Ernst Lunding has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2008, Nina Sølver Henning has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2008, Ernst Lunding is registered as adm. dir. of LEO PHARMA A/S.
As of January 1, 2008, Gitte Pugholm Aabo is registered as adm. dir. of LEO PHARMA A/S.
As of December 31, 2007, Poul Rødbroe Rasmussen has left the board of directors of LEO PHARMA A/S.
As of December 31, 2007, Ernst Lunding has stepped down as adm. dir. of LEO PHARMA A/S.
As of October 31, 2007, Karin Attermann has joined the board of directors of LEO PHARMA A/S.
As of October 31, 2007, Karin Attermann has left the board of directors of LEO PHARMA A/S.
As of October 31, 2007, Jesper Møller Hougaard has left the board of directors of LEO PHARMA A/S.
As of May 1, 2007, Lars Olsen is registered as director of LEO PHARMA A/S.
As of January 1, 2007, Judith Blankholm has joined the board of directors of LEO PHARMA A/S.
As of January 1, 2007, Gitte Pugholm Aabo has joined the board of directors of LEO PHARMA A/S.
As of December 31, 2006, Judith Blankholm has left the board of directors of LEO PHARMA A/S.
As of December 31, 2006, Niels Smidt Rastrup Andersen has left the board of directors of LEO PHARMA A/S.
As of December 31, 2006, Patrick Joseph O'Sullivan has left the board of directors of LEO PHARMA A/S.
As of April 1, 2006, John Carsten Mehlbye is registered as director of LEO PHARMA A/S.
As of February 1, 2006, Birgitte Pryds has joined the board of directors of LEO PHARMA A/S.
As of February 1, 2006, Karin Attermann has joined the board of directors of LEO PHARMA A/S.
As of February 1, 2006, Jesper Møller Hougaard has joined the board of directors of LEO PHARMA A/S.
As of February 1, 2006, Brian Juel Pedersen has left the board of directors of LEO PHARMA A/S.
As of June 30, 2005, Erik Torngaard Hansen has stepped down as director of LEO PHARMA A/S.
As of September 1, 2003, Karin Bredal Jensen has left the board of directors of LEO PHARMA A/S.
As of June 3, 2003, RVT REVISIONSTJENESTEN A/S has stepped down as auditor of LEO PHARMA A/S.
As of April 30, 2003, RVT REVISIONSTJENESTEN A/S has been appointed auditor of LEO PHARMA A/S.
As of April 30, 2003, RVT REVISIONSTJENESTEN A/S has been appointed auditor of LEO PHARMA A/S.
As of April 30, 2003, CHRISTIANSEN & ENGELBRECHTSEN REVISIONSFIRMA has stepped down as auditor of LEO PHARMA A/S.
As of April 23, 2002, Karin Bredal Jensen has joined the board of directors of LEO PHARMA A/S.
As of April 23, 2002, Judith Blankholm has joined the board of directors of LEO PHARMA A/S.
As of April 23, 2002, Brian Juel Pedersen has joined the board of directors of LEO PHARMA A/S.
As of April 23, 2002, Grethe Karin Hansen has left the board of directors of LEO PHARMA A/S.
As of April 23, 2002, Jette Rattenborg Thomsen has left the board of directors of LEO PHARMA A/S.
As of April 23, 2002, Hanne Ann-Dorthe Ginderskov has left the board of directors of LEO PHARMA A/S.
On March 8, 2002, the company changed its name from LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB to LEO PHARMA A/S.
As of December 12, 2000, Per Håkon Schmidt has joined the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Poul Rødbroe Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Poul Rødbroe Rasmussen has joined the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Jens Bo Olesen has joined the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Aage Cato Spang-Hanssen has left the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Poul Rødbroe Rasmussen has left the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Helmuth Nielsen has left the board of directors of LEO PHARMA A/S.
As of December 12, 2000, Poul Rødbroe Rasmussen has stepped down as director of LEO PHARMA A/S.
As of December 14, 1999, Gorm Milan Thamsborg has joined the board of directors of LEO PHARMA A/S.
As of December 14, 1999, Vagn Ole Godtfredsen has left the board of directors of LEO PHARMA A/S.
As of September 1, 1999, Erik Torngaard Hansen is registered as director of LEO PHARMA A/S.
As of September 1, 1999, Jens Bo Olesen is registered as director of LEO PHARMA A/S.
As of April 28, 1998, Judith Blankholm has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Grethe Karin Hansen has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Hanne Ann-Dorthe Ginderskov has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Hanne Ann-Dorthe Ginderskov has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Jannie Kogsbøll has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Jannie Kogsbøll has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Judith Blankholm has left the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Arne Stolting has left the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Jette Rattenborg Thomsen has left the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Hanne Ann-Dorthe Ginderskov has left the board of directors of LEO PHARMA A/S.
As of April 28, 1998, Jannie Kogsbøll has left the board of directors of LEO PHARMA A/S.
As of April 29, 1997, Aage Cato Spang-Hanssen has joined the board of directors of LEO PHARMA A/S.
As of April 29, 1997, Hans Christian Bang has left the board of directors of LEO PHARMA A/S.
As of April 28, 1997, Jette Rattenborg Thomsen has joined the board of directors of LEO PHARMA A/S.
As of April 28, 1997, Jette Rattenborg Thomsen has joined the board of directors of LEO PHARMA A/S.
As of May 7, 1996, Vilhelm Johannes Kahlke has left the board of directors of LEO PHARMA A/S.
As of May 7, 1996, Erling Finn Juhl Nielsen has left the board of directors of LEO PHARMA A/S.
As of December 29, 1994, Jørgen Halsteen has stepped down as director of LEO PHARMA A/S.
As of December 29, 1994, Helmuth Nielsen has stepped down as adm. dir. of LEO PHARMA A/S.
As of June 14, 1994, Carl-Aage Lund has left the board of directors of LEO PHARMA A/S.
As of June 14, 1994, Ingelise Sørensen has left the board of directors of LEO PHARMA A/S.
As of June 14, 1994, Morten Ryskjær has left the board of directors of LEO PHARMA A/S.
As of January 11, 1994, Arne Victor Hansen has left the board of directors of LEO PHARMA A/S.
As of May 26, 1992, Vagn Ole Godtfredsen has stepped down as director of LEO PHARMA A/S.
As of August 31, 1990, Axel Emil Jacobsen has stepped down as auditor of LEO PHARMA A/S.
As of June 19, 1990, Anna Elisabeth Gundersen has left the board of directors of LEO PHARMA A/S.
As of June 19, 1990, Berit van Arkens has left the board of directors of LEO PHARMA A/S.
As of June 19, 1990, Grethe Karin Hansen has left the board of directors of LEO PHARMA A/S.
As of May 26, 1988, Carthon Christoffer Cecil Valdemar Nyholm Treschow has left the board of directors of LEO PHARMA A/S.
As of May 26, 1988, Erling Finn Juhl Nielsen has stepped down as director of LEO PHARMA A/S.
As of February 10, 1962, Axel Emil Jacobsen has been appointed auditor of LEO PHARMA A/S.
As of February 10, 1962, CHRISTIANSEN & ENGELBRECHTSEN REVISIONSFIRMA has been appointed auditor of LEO PHARMA A/S.
As of February 10, 1962, Vilhelm Johannes Kahlke has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Carthon Christoffer Cecil Valdemar Nyholm Treschow has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Carl-Aage Lund has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Arne Victor Hansen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Anna Elisabeth Gundersen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Erling Finn Juhl Nielsen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Berit van Arkens has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Grethe Karin Hansen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Ingelise Sørensen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Vagn Ole Godtfredsen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Niels Smidt Rastrup Andersen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Morten Ryskjær has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Arne Stolting has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Helmuth Nielsen has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Hans Christian Bang has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Patrick Joseph O'Sullivan has joined the board of directors of LEO PHARMA A/S.
As of February 10, 1962, Jørgen Halsteen is registered as director of LEO PHARMA A/S.
As of February 10, 1962, Erling Finn Juhl Nielsen is registered as director of LEO PHARMA A/S.
As of February 10, 1962, Vagn Ole Godtfredsen is registered as director of LEO PHARMA A/S.
As of February 10, 1962, Poul Rødbroe Rasmussen is registered as director of LEO PHARMA A/S.
As of February 10, 1962, Helmuth Nielsen is registered as adm. dir. of LEO PHARMA A/S.
LEO PHARMA A/S was founded on February 10, 1962.
1 news item or press release
TRAPEDS-1 is a Phase 2 trial evaluating the pharmacokinetics and long-term safety of tralokinumab in children aged 6 to 11 years with moderate-to-severe atopic dermatitis.1 The pharmacokinetic profile was as expected and consistent with what has previously been observed with tralokinumab. Tralokinumab was generally well tolerated for up to 172 weeks of treatment, with no new safety signals identified.
Sources: Via Ritzau and Danish news media. Links open at the source.
Companies in the same industry and area
CVR 26411238
CVR 36423641
CVR 39038323
CVR 40868151
CVR 46003780
companydata.dk